Please click for
HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg),
EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg),
SOVALDI® (sofosbuvir 400 mg), and
VOSEVI (sofosbuvir 400 mg/velpatasvir 100
mg/voxilaprevir 100 mg)

full Prescribing Information, including
BOXED WARNING.

Get Updates

Register for updates on Support Path and other relevant products

*Indicates required fields

Please enter the required information.

Terms and Conditions

Gilead respects the privacy of your personal information. Gilead, and companies providing services to Gilead, may use the information that you provide to send you marketing or informational materials, analyze and use your information to improve or develop services and programs, and contact you about marketing programs or research and health topics that may be of interest to you.

Gilead, and companies providing services to Gilead, will not sell or rent your personally identifiable information. For more information regarding our Privacy Policy, click here.

Please select a product:

HARVONI, the HARVONI logo, EPCLUSA, the EPCLUSA logo, SOVALDI, the SOVALDI logo, SUPPORT PATH, the SUPPORT PATH logo, VOSEVI, the VOSEVI logo, GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc., or its related companies. All other trademarks herein are the property of their respective owners.

©2017 Gilead Sciences, Inc. All rights reserved. PTFP0833 7/17

By following this link, you are now leaving www.mysupportpath.com. The site you are entering is not controlled by Gilead Sciences, Inc., and Gilead is not responsible for its content or your use of it.